Patients with congestive heart failure (CHF) are less likely to be discharged from the hospital with a prescription for an ACE inhibitor and other recommended medications if they are treated by a non-cardiologist, according to a study written by pharmacists at Northwestern Memorial Hospital and published January 15 in the American Journal of Health-System Pharmacy. Beta-blockers, ACE inhibitors, and aldosterone antagonists have been shown to significantly decrease morbidity and mortality and are among the medications recommended by the Heart Failure Society of America (HFSA) to treat CHF, which affects nearly 5 million Americans.

Prescribing differences were demonstrated for several key medications, including:

• ACE inhibitor (prescribed for 61 percent of patients upon discharge by cardiologists versus 35 percent by non-cardiologists)

• Beta-blocker (prescribed for 65 percent of patients upon discharge by a cardiologist versus 32 percent by non-cardiologists)

• Aldosterone antagonist (prescribed for 17 percent of patients upon discharge by a cardiologist versus 7 percent by non-cardiologists)

The study also found that cardiologists are more likely to admit a CHF patient to the Intensive Care Unit and order diagnostic tests, including chest x-rays, electrocardiograms, nuclear medicine tests, cardiac catheterizations, and stress tests, without significantly increasing a patient's length of stay.

Study authors urge patients to take an active role in their treatment and ask about available medications. "Furthermore, patients or their family members should ask to speak to the hospital pharmacist whenever they have questions about their medicine," explains Jean A. Patel, Pharm. D., clinical pharmacist at Northwestern Memorial Hospital and lead author of the study.

The study was co-authored by Michael A. Fotis, B.S. Pharm, manager of drug information service at Northwestern Memorial Hospital.
'"/>

Contact: Patty Keiler
312-926-5900
Northwestern Memorial Hospital
13-Jan-2005

Page: 1 2
Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Heart surgeons publish death rates
3. Heart attack treatment gap may be closing for women
4. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
5. Brenner Childrens Hospital named to NIH Pediatric Heart Network
6. Heart failure patients treated for diabetes with insulin have increase in mortality
7. New research results: Heart jacket shown to be effective
8. Heart surgery patients receive less aggressive discharge care
9. Heart attack, stroke risk overlooked in diabetics
10. Heart arrhythmias easily treated, yet few know risks
11. Donald W. Reynolds Foundation awards UT Southwestern $12 million to continue Dallas Heart Study